Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients

Rheumatology

Volumn 46, Issue 4, 2007, Pages 608-611

  Kapetanovic, Meliha Crnkic ^a   Saxne, T ^a   Nilsson, J A ^a   Geborek, P ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibody response; Influenza vaccination; Methotrexate; Prednisolone; Rheumatoid arthritis; TNF blockers

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HEMAGGLUTINATION INHIBITING ANTIBODY; INACTIVATED VACCINE; INFLIXIMAB; INFLUENZA VACCINE; INFLUVAX; METHOTREXATE; TRIPLE VACCINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MAJOR CLINICAL STUDY; MONOTHERAPY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROLOGY; TREATMENT DURATION; VIRUS STRAIN;

ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOCOMPETENCE; IMMUNOGLOBULIN G; INFLUENZA VACCINES; MALE; METHOTREXATE; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

EID: 34047190402     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel366     Document Type: Article

References (20)

1. Recommendations of the Swedish National Board of Health and Welfare. Influenza Vaccination. (Socialstyrelsens allmäna råd. Vaccination mot influenzH. SOSFS 1997:21). Available at: http://www.sos.se/sosfs/1997_21/1997_21.htm (Accessed 22 December 2005).
2. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5408a1.htm (Accessed 22 December 2005).
3. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003;362:1733-45.
4. Thompson WW, Shay DK, Weintraub E et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292:1333-40.
5. Nordin J, Mullooly J, Poblete S et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: Data from 3 health plans. J Infect Dis 2001;184:665-70.
6. Kelly H, Vu T, Smith D. Influenza vaccination and mortality in the United States. Arch Intern Med 2005;165:2037-8.
7. Nichol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999;159:2437-42.
8. Colquhoun AJ, Nicholson KG, Botha JL, Raymond NT. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes. Epidemiol Infect 1997;119:335-41.
9. Christenson B, Hedlund J, Lundbergh P, Ortqvist A. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004;23:363-8.
10. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002;46:2287-229.
11. Crum NF, Lederman ER, Wallace MR. Infections associated with tumour necrosis factor-alpha antagonists. Medicine 2005;84:291-302.
12. Chalmers A, Scheifele D, Patterson C et al. Immunization of patients with rheumatoid arthritis against influenza: A study of vaccine safety and immunogenicity. J Rheumatol 1994;21:1203-6.
13. Francioni C, Rosi P, Fioravanti A, Megale F, Pipitone N, Marcolongo R. Vaccination against influenza in patients with rheumatoid arthritis: clinical and antibody response. Recent Prog Med 1996;87:145-9.
14. Kapetanovic MC, Saxne T, Sjoholm A, Truedsson L, Jonsson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology 2006;45:106-11.
15. WHO. Recommendations for Influenza Vaccine Composition. Available at: www.who.int/csr/disease/influenza/vaccine recommendations1 (Accessed 9 January 2006).
16. WHO Collaborating Centre for Influenza Viruses. Version 31, revised 1981, pp. 1-81.
17. Fomin I, Caspi D, Levy V et al. Vaccination against influenza in rheumatoid arthritis: The effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 2006;65:191-4.
18. Van der Bijl AE, Gelinck LB, Breedveld FC et al. Anti-TNF-alpha inhibits the antibody response to influenza vaccination. Ann Rheum Dis 2005;(Suppl III):181.
19. Moreland LW, Bucy RP, Weinblatt ME, Mohler KM, Spencer-Green GT, Chatham WW. Immune function in patients with rheumatoid arthritis treated with etanercept. Clin Immunol 2002;103:13-21.
20. Avery RK. Vaccination of the immunosuppressed adult patient with rheumatologic disease. Rheum Dis Clin North Am 1999;25:567-84, viii.